Botox is a neurotoxic protein formed by the
bacterium clostridium botulinum & related species in the reproduction
process. Botox is a polypeptide with 150kD molecular weight. It is one of the
most poisonous natural proteins. It comprises a highly purified botulinum-toxin
protein. It is easy to be produced, purified and refined owing to its stable
property. It initiates the release of acetylcholine (ACH), which is a
neurotransmitter, responsible for actuating glandular secretions & muscle
contraction. It is a non-invasive procedure and is approved by the Food and
Drug Administration (FDA) in treating many health conditions. It is
commercially viable for patients, patients may notice the results of Botox
immediately. It is used to reduce fine lines & wrinkles by paralyzing the
underlying muscles, also known as miracle wrinkler-eraser. The most frequently
treated areas, where muscle activity influences facial features includes
wrinkles around the eyes, such as crow’s feet, glabellar lines, corners of the
mouth, forehead creases and cobblestoned appearance to the chin. It is widely
used in experimental research and clinical application at the early stage.
The key benefits are included shorter hospital
stay, small incision, and rapid wound healing. Apart from benefits, some of the
side-effects are included allergic reactions, shortness of breath, neck &
back pain, rash, difficulty in swallowing, and nausea.
According to study, “World
Botox Market Research Report 2024(covering USA, EU, China, South East Asia,
Japan and etc)” the key companies operating in the world Botox market
are Lanzhou Institute of Biological Products Co. Ltd. (LIBP), US World Meds
LLC, Revance Therapeutics Inc., Allergan Inc., Medytox Inc., Merz
Pharmaceuticals GmbH and Co. KGaA, Ipsen Group. The key companies are focusing
on the research endeavors in order to introduce innovative therapeutic
applications of the existing products.
Based on type, Botox market is segmented into
Botox type A and Botox type B. Botox type A and Botox type B are used in
medicine for upper motor neuron syndrome, strabismus, chronic migraine, focal
hyperhidrosis, and bruxism. Based on application, market is segmented into
cosmetic and medical. In addition, based on end-use, market is segmented into
outpatient centers and hospitals cosmetic centers.
The Botox market is driven by rise in demand
for minimally invasive treatment, followed by growth in population aging
between 25 to 65 years of age, introduction of new & improved products,
rise in awareness level regarding non-surgical esthetic & therapeutic
procedures, increase in prevalence of cervical dystonia, glabellar lines,
spasticity & crow’s foot, favorable government regulations, increase in
investment on research & development (R&D) projects and expand in
therapeutic use of botulinum toxin. However, limited reimbursement coverage,
high cost entailed in performing such expensive procedures, risk of side
effects and misuse as bioterrorism may impact the market.
Based on geography, USA country holds
major share, followed by EU in Botox market owing to increase in availability
of a variety of aesthetic procedures and higher disposable income of the
individuals in the country. China country is expected to witness higher growth
rate due to increase in geriatric population over the forecast period. The
market is expected to grow at a CAGR of approximately 13.3% over the next five
years, will reach US $8500million in 2024, from US $4550 million in 2019.
For more information, click on the
link below:
Contact Us:
Ken Research
Ankur Gupta, Head Marketing &
Communications
+91
9015378249